The 2003 SARS outbreaks in Taiwan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Severe acute respiratory syndrome (SARS) is caused by SARS-associated coronaviruses (SARS-CoVs) (Drosten et al., 2003; Fouchier et al., 2003; Peiris et al., 2003b; Ksiazek et al., 2003). The first known outbreak of SARS occurred in China's Guangdong province in November, 2002 (Chinese SARS Molecular Epidemiology Consortium, 2004). By August 7 of the following year, SARS had spread to more than 30 countries, affecting 8,096 people and resulting in 774 deaths worldwide (World Health Organization, 2004). In 2003, Taiwan experienced a series of SARS outbreaks and the Municipal Hoping Hospital (referred to hereafter as HP) in Taipei City suffered the first and the most serious outbreak of SARS-CoV nosocomial infections: 137 probable cases and 26 deaths (Division of Surveillance and Investigation, Center for Disease Control, Taiwan, 2003; Lan et al., 2005b). According to the Center for Disease Control (CDC) in Taiwan, 364 of the 664 probable Taiwanese SARS cases reported to the World Health Organization were confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and/or neutralizing antibody tests (Center for Disease Control, 2003a). In this chapter, we will discuss the molecular and clinical epidemiology of SARS infection in Taiwan during 2003.

Original languageEnglish
Title of host publicationEmerging Infections in Asia
PublisherSpringer US
Pages117-129
Number of pages13
ISBN (Print)9780387757216
DOIs
Publication statusPublished - Dec 1 2008
Externally publishedYes

Fingerprint

Severe Acute Respiratory Syndrome
Taiwan
Disease Outbreaks
Centers for Disease Control and Prevention (U.S.)
Molecular Epidemiology
Municipal Hospitals
Coronavirus
Cross Infection
Neutralizing Antibodies
Reverse Transcriptase Polymerase Chain Reaction
Respiratory Tract Infections
China

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chen, Y. M. A. (2008). The 2003 SARS outbreaks in Taiwan. In Emerging Infections in Asia (pp. 117-129). Springer US. https://doi.org/10.1007/978-0-387-75722-3_7

The 2003 SARS outbreaks in Taiwan. / Chen, Yi Ming Arthur.

Emerging Infections in Asia. Springer US, 2008. p. 117-129.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, YMA 2008, The 2003 SARS outbreaks in Taiwan. in Emerging Infections in Asia. Springer US, pp. 117-129. https://doi.org/10.1007/978-0-387-75722-3_7
Chen YMA. The 2003 SARS outbreaks in Taiwan. In Emerging Infections in Asia. Springer US. 2008. p. 117-129 https://doi.org/10.1007/978-0-387-75722-3_7
Chen, Yi Ming Arthur. / The 2003 SARS outbreaks in Taiwan. Emerging Infections in Asia. Springer US, 2008. pp. 117-129
@inbook{c6580b31a4124a46858ffe83e1ce92c4,
title = "The 2003 SARS outbreaks in Taiwan",
abstract = "Severe acute respiratory syndrome (SARS) is caused by SARS-associated coronaviruses (SARS-CoVs) (Drosten et al., 2003; Fouchier et al., 2003; Peiris et al., 2003b; Ksiazek et al., 2003). The first known outbreak of SARS occurred in China's Guangdong province in November, 2002 (Chinese SARS Molecular Epidemiology Consortium, 2004). By August 7 of the following year, SARS had spread to more than 30 countries, affecting 8,096 people and resulting in 774 deaths worldwide (World Health Organization, 2004). In 2003, Taiwan experienced a series of SARS outbreaks and the Municipal Hoping Hospital (referred to hereafter as HP) in Taipei City suffered the first and the most serious outbreak of SARS-CoV nosocomial infections: 137 probable cases and 26 deaths (Division of Surveillance and Investigation, Center for Disease Control, Taiwan, 2003; Lan et al., 2005b). According to the Center for Disease Control (CDC) in Taiwan, 364 of the 664 probable Taiwanese SARS cases reported to the World Health Organization were confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and/or neutralizing antibody tests (Center for Disease Control, 2003a). In this chapter, we will discuss the molecular and clinical epidemiology of SARS infection in Taiwan during 2003.",
author = "Chen, {Yi Ming Arthur}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-0-387-75722-3_7",
language = "English",
isbn = "9780387757216",
pages = "117--129",
booktitle = "Emerging Infections in Asia",
publisher = "Springer US",

}

TY - CHAP

T1 - The 2003 SARS outbreaks in Taiwan

AU - Chen, Yi Ming Arthur

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Severe acute respiratory syndrome (SARS) is caused by SARS-associated coronaviruses (SARS-CoVs) (Drosten et al., 2003; Fouchier et al., 2003; Peiris et al., 2003b; Ksiazek et al., 2003). The first known outbreak of SARS occurred in China's Guangdong province in November, 2002 (Chinese SARS Molecular Epidemiology Consortium, 2004). By August 7 of the following year, SARS had spread to more than 30 countries, affecting 8,096 people and resulting in 774 deaths worldwide (World Health Organization, 2004). In 2003, Taiwan experienced a series of SARS outbreaks and the Municipal Hoping Hospital (referred to hereafter as HP) in Taipei City suffered the first and the most serious outbreak of SARS-CoV nosocomial infections: 137 probable cases and 26 deaths (Division of Surveillance and Investigation, Center for Disease Control, Taiwan, 2003; Lan et al., 2005b). According to the Center for Disease Control (CDC) in Taiwan, 364 of the 664 probable Taiwanese SARS cases reported to the World Health Organization were confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and/or neutralizing antibody tests (Center for Disease Control, 2003a). In this chapter, we will discuss the molecular and clinical epidemiology of SARS infection in Taiwan during 2003.

AB - Severe acute respiratory syndrome (SARS) is caused by SARS-associated coronaviruses (SARS-CoVs) (Drosten et al., 2003; Fouchier et al., 2003; Peiris et al., 2003b; Ksiazek et al., 2003). The first known outbreak of SARS occurred in China's Guangdong province in November, 2002 (Chinese SARS Molecular Epidemiology Consortium, 2004). By August 7 of the following year, SARS had spread to more than 30 countries, affecting 8,096 people and resulting in 774 deaths worldwide (World Health Organization, 2004). In 2003, Taiwan experienced a series of SARS outbreaks and the Municipal Hoping Hospital (referred to hereafter as HP) in Taipei City suffered the first and the most serious outbreak of SARS-CoV nosocomial infections: 137 probable cases and 26 deaths (Division of Surveillance and Investigation, Center for Disease Control, Taiwan, 2003; Lan et al., 2005b). According to the Center for Disease Control (CDC) in Taiwan, 364 of the 664 probable Taiwanese SARS cases reported to the World Health Organization were confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and/or neutralizing antibody tests (Center for Disease Control, 2003a). In this chapter, we will discuss the molecular and clinical epidemiology of SARS infection in Taiwan during 2003.

UR - http://www.scopus.com/inward/record.url?scp=84892810979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892810979&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-75722-3_7

DO - 10.1007/978-0-387-75722-3_7

M3 - Chapter

SN - 9780387757216

SP - 117

EP - 129

BT - Emerging Infections in Asia

PB - Springer US

ER -